We identified that expression of IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL are associated with a shorter overall survival of pancreatic cancer patients (Figure 3), whereas the expression of the other 16 genes are not associated with the overall survival of pancreatic cancer patients (not shown). This evidence concerns the gene MMP1 and familial pancreatic carcinoma.